See also this year's filing and all EDGAR filings for this company.
PDF Report 0000847464_2017_Spring_Pharmaceutical_Group_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments'} |
Graph
Absolute values for 0000847464, Spring Pharmaceutical Group INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 0 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 12,295,147 |
| 2 | PropertyPlantAndEquipmentNet | 12,872,997 |
| 3 | remainder_Assets | 56,110,723 |
| 4 | LiabilitiesCurrent | 929,316 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 0 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 38,537,551 |
| 11 | remainder_Revenues | 43,501,226 |
| 12 | remainder_NetIncome | 31,317 |
| 13 | remainder_ComprehensiveNetIncome | -25,698,696 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 81,278,867 |
| 1 | Liabilities | 929,316 |
| 2 | Expenses | 38,537,551 |
| 3 | Revenues | 43,501,226 |
| 4 | StockholdersEquity | 80,349,551 |
| 5 | NetIncome | 4,994,992 |
| 6 | ComprehensiveNetIncome | -7,854,356 |
| 7 | BaseVar | 94,988,486 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.07 |
| 9 | EconomicCapitalRatio | 4.45 |
Edgar->Model Mapping
Feature Distribution
Change over Time
